56217-81-3

Basic information

• Product Name: Phenylalanine, N-(1-oxohexadecyl)-
• CAS NO: 56217-81-3
• Molecular Formula: C25H41NO3
• Molecular Weight: 403.605
• Mol File: 56217-81-3.mol
• Article Data: 20

Chemical Properties

• CAS DataBase Reference: Phenylalanine, N-(1-oxohexadecyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenylalanine, N-(1-oxohexadecyl)-(56217-81-3)
• EPA Substance Registry System: Phenylalanine, N-(1-oxohexadecyl)-(56217-81-3)

Safety Data

• Hazardous Substances Data: 56217-81-3(Hazardous Substances Data)

Upstream product

• 150-30-1 Phenylalanine 
• 112-67-4 n-hexadecanoyl chloride 
• 63-91-2 L-phenylalanine 
• 81912-43-8 rac.-3-hexadecanoyl-4-methoxycarbonyl-1,3-thiazolidine-2-thione 
• 81912-47-2 N-n-hexadecanoyl methyl (L)-phenylalaninate 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 
• 57-10-3 1-hexadecylcarboxylic acid 
• 75531-09-8 p-nitrophenyl N-hexadecanoyl-L-alanate 
• 75531-09-8 p-nitrophenyl N-hexadecanoyl-D-alanate 
• 14464-31-4 palmitic acid N-succinimide ester 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 
• 75531-13-4 p-Nitrophenyl N-hexadecanoyl-L-phenylalaninate 
• 1492-30-4 4-nitrophenyl palmitate 

Downstream Products

• 1147761-30-5 C₃₀H₅₀N₂O₄ 
• 1147761-38-3 C₃₆H₅₁N₃O₄ 
• 1351017-43-0 C₃₇H₆₂N₂O₁₂ 
• 1351017-35-0 N-propargyl (N'-palmitoylphenylalanine) amide 

Relevant articles and documents

CHEMICAL UNCOUPLERS OF RESPIRATION AND METHODS OF USE THEREOF

Uncoupling of respiration is a well-recognized process that increases respiration and heat production in cells. Provided herein are chemical uncouplers of respiration that are compounds of Formula (I). Also provided are methods for preventing or treating metabolic disorders and modulating metabolic processes using compound of Formula (I).

HUMAN MICROBIOTA DERIVED N-ACYL AMIDES FOR THE TREATMENT OF HUMAN DISEASE

The present invention provides compositions and methods for the modulation of G protein-coupled receptors (GPCRs). The invention provides a genetically engineered cell, wherein the cell expresses a human microbial N-acyl synthase (hm-NAS) gene. In one embodiment, the hm-NAS gene is N-acyl serinol synthase. The invention provides a probiotic composition, the probiotic composition comprises a genetically engineered cell of the invention. The invention provides a method for modulating a G protein-coupled receptor (GPCR) activity in a subject, the method comprises administering to the subject an effective amount of a composition comprising at least one selected from the group consisting of a genetically engineered cell, an hm-NAS gene, and a N-acyl amide.

METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS

The present invention relates to methods for identifying, assessing, preventing, and treating metabolic disorders and modulating metabolic processes using PM20D1 and N- lipidated amino acids.